CHMP denies Merck KGaA’s appeal on Cladribine: http://www.reuters.com/article/idUSLDE70K05G20110121?feedType=RSS&feedName=rbssHealthcareNews&rpc=43 The FDA PDUFA date is next month (#msg-57103405), but the odds do not look good.